Identification of Circulating Long Noncoding RNA Linc00152 as a Novel Biomarker for Diagnosis and Monitoring of Non-Small-Cell Lung Cancer

Table 3

Use of Linc00152 and CEA levels to distinguish NSCLC patients from healthy control.

	SEN	SPE	AC	PPV	NPV
Linc00152	80.0%	72.0%	76.0%	74.1%	78.3%
CEA	44.0%	86.0%	65.0%	75.9%	60.6%
Linc00152 + CEA	76.0%	83.0%	79.5%	81.7%	77.6%

SEN: sensitivity; SPE: specificity; AC: diagnostic accuracy; PPV: positive predictive value; NPV: negative predictive value.